- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01728415
Effects of High-intensity Interval Training in Patients in Hemodialysis (OsloExDia)
September 19, 2014 updated by: Birgitta Blakstad Nilsson, PhD, Oslo University Hospital
The purpose of this study is to evaluate the effects of high intensity interval training compared to moderate exercise training and a control group on exercise capacity and quality of life in patients with end stage renal disease on hemodialysis.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Postboks 4950 Nydalen
-
Oslo, Postboks 4950 Nydalen, Norway, 0424
- Recruiting
- Oslo University Hospital
-
Contact:
- Birgitta Blakstad Nilsson, PhD
- Phone Number: +47 93210913
-
Principal Investigator:
- Heidi B Næss
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients on hemodialysis ≥ 3 months
Exclusion Criteria:
- Acute infection
- Systolic BP>180 mmHG or diabolic BP>105 mmHG
- Unstable angina pectoris
- Serious rhythm disturbances
- Hyperkalemic (> 6 mmol/L),
- Unstable diabetes mellitus
- Wheelchair
- Dialyses access on lower extremities
- Haemoglobin < 9 g/dl
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A: Exercise
High intensity interval exercise training (3 x 3 minutes of intensity abow 85% og Heart rate peak)
|
Group A: high intensity exercise training Group B: moderate intensity exercise training C: Control group
|
|
Active Comparator: B: Execise
Moderate continuous exercise training
|
Group A: high intensity exercise training Group B: moderate intensity exercise training C: Control group
|
|
No Intervention: C: Controll
Usual care without exercise training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak oxygen uptake
Time Frame: baseline, 16 weeks
|
Canges from baseline in peak oxygen uptake at 16 weeks
|
baseline, 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Anticipated)
December 1, 2014
Study Completion (Anticipated)
September 1, 2016
Study Registration Dates
First Submitted
November 13, 2012
First Submitted That Met QC Criteria
November 13, 2012
First Posted (Estimate)
November 19, 2012
Study Record Updates
Last Update Posted (Estimate)
September 22, 2014
Last Update Submitted That Met QC Criteria
September 19, 2014
Last Verified
September 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012/1459
- 126/12-303.0 (Other Grant/Funding Number: The Norwegian Fund for Post-Graduate Training in Physiotherapy)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.